Publication | Closed Access

MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte–associated antigen 4

InflammationAtopic DermatitisImmune Cell DevelopmentImmunodeficienciesMedicineImmunologyImmune RegulationTumor ImmunityT-regulatory CellAutoimmunityT Cell ImmunityCd4 T Cell ResponsesDermatologyImmune SystemImmunotherapyAntigen 4Cytotoxic THypersensitivity